Classification
Product TypeIngredient
Product FormPowder (micronutrient ingredient)
Industry PositionMicronutrient ingredient for supplements and food fortification
Market
In India, riboflavin (vitamin B2) is an allowed vitamin ingredient for FSSAI-regulated health supplements and nutraceutical products, with Schedule I listing riboflavin and riboflavin 5′-phosphate (sodium) as vitamin B2 components. Products marketed as health supplements or nutraceuticals must carry specific label statements (including “NOT FOR MEDICINAL USE”) and provide nutrient quantity declarations (including %RDA where applicable). Imported consignments are subject to FSSAI’s Import Regulations and port-of-entry clearance via an Authorised Officer-issued No Objection Certificate, with limited in-customs label rectification allowed in certain cases. Riboflavin is also referenced in India’s fortification framework as a permitted micronutrient source for certain fortified foods, supporting demand from premix and fortified-food supply chains.
Market RoleRegulated domestic consumption and formulation market (health supplements/nutraceuticals and food fortification); domestic riboflavin primary production status not verified in this record.
Domestic RoleUsed as a vitamin B2 input for health supplement/nutraceutical dose forms and for fortified-food premixes under Indian food regulations.
Market Growth
Specification
Compositional Metrics- FSSAI nutraceutical regulations list a permissible overage of 25% for riboflavin (vitamin B2) for applicable products.
Supply Chain
Value Chain- Riboflavin ingredient procurement → premix blending (where used) → dose-form manufacture (tablet/capsule/sachet formats) → FSSAI-compliant labelling → distribution in India.
Risks
Regulatory Compliance HighNon-compliance with India’s FSSAI health supplement/nutraceutical requirements (including permitted vitamin B2 forms, mandatory “NOT FOR MEDICINAL USE” advisory, %RDA/nutrient declarations, and other label warnings) can block market access through port-of-entry delays, mandatory re-labelling, non-conformance outcomes, or rejection.Run a pre-shipment India label and formulation compliance review against FSSAI Health Supplements/Nutraceuticals rules and Labelling & Display rules; verify vitamin B2 source form matches Schedule I and ensure mandatory advisories and %RDA/nutrient declarations are correctly presented.
Documentation Gap MediumInconsistencies between declared nutrient content/label statements and supporting composition/specification documentation can trigger extended scrutiny, corrective actions, or delays in obtaining an FSSAI No Objection Certificate for clearance.Align COA/specifications, ingredient statements, and label nutrient declarations; retain batch records and ensure importer documentation packages are complete before arrival.
Marketing Claims MediumDisease prevention/treatment/cure-type claims are restricted for products positioned under the health supplement/nutraceutical framework; non-compliant claims and presentations can prompt enforcement and forced relabeling.Review all product claims and marketing copy for alignment with FSSAI health supplement/nutraceutical claim restrictions and required advisory statements.
FAQ
Which vitamin B2 forms are explicitly listed as permitted components for India’s health supplement/nutraceutical framework?FSSAI’s Health Supplements/Nutraceuticals regulations list vitamin B2 components in Schedule I as riboflavin and riboflavin 5′-phosphate (sodium).
What advisory statement is commonly mandatory on health supplement or nutraceutical labels in India?For health supplements and nutraceuticals, FSSAI’s regulations require an advisory warning “NOT FOR MEDICINAL USE” to be prominently displayed, along with related usage warnings (e.g., not exceeding the recommended daily usage) and nutrient quantity declarations (including %RDA where applicable).
If an imported riboflavin-containing product has a labeling issue, can it be corrected at the Indian port?Under FSSAI’s Import Regulations, an Authorised Officer may direct permissible labelling rectifications within the customs area in certain cases, provided the rectification does not alter or mask the original label information.